Xuemei Tan
About Xuemei Tan
Xuemei Tan is the Medical Director at BeiGene with over 20 years of experience in clinical research and medical affairs.
Company
Xuemei Tan currently works at BeiGene as a Medical Director. She joined BeiGene in April 2016. BeiGene is a global biotechnology company focused on molecularly targeted and immuno-oncology drug development.
Title
Xuemei Tan holds the title of Medical Director at BeiGene. In this role, she oversees medical affairs, including clinical research and development, with a focus on oncology.
Background in Clinical Research
Xuemei Tan has over 20 years of experience in clinical research and medical affairs. She has managed and led numerous clinical trials during her career. Her background includes extensive work in pharmaceutical research and clinical practice, particularly in the fields of oncology and ophthalmology.
Previous Roles at Novartis
Xuemei Tan has held various roles at Novartis over more than a decade. She started as a Clinical Research Associate at Beijing Novartis Pharma Ltd., later becoming Senior Clinical Research Associate. She progressed to roles such as Group Head of the Oncology/Ophtha group and Clinical Research Manager. From 2006 to 2011, she served as CRO Manager before becoming a Clinical Trial Leader at Novartis Institutes for BioMedical Research from 2011 to 2015.
Education and Expertise
Xuemei Tan studied at Henan Medical University where she obtained a Bachelor's degree in Clinical Medicine. She later attended Peking University and earned a Beijing International MBA. Her education has provided a strong foundation in both clinical practice and business management, enhancing her expertise in managing clinical trials and leading research teams.